Hepion Pharmaceuticals, Inc. - 8-K Filing
Hepion Pharmaceuticals issued a $500,000 secured convertible note to Gravitas Capital with attached warrant on September 3, 2026. (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, 3.02 Unregistered Sale of Equity Securities, 9.01 Financial Statements and Exhibits)
Tickers: $HEPA